It is anticipated that the closing of the transfer will occur on or before April 1, 2011. Management of the Company will seek to apply the net proceeds of the transaction to the acquisition of one or more new businesses. _____________________
...looking at the most recent Financials she is trading at about 2 to 3x earnings, way low for a decent Pharma Company which trades 9-20x earnings.....low OS and just up from Bottom.....Weekly is Choppy, Daily Improving, ......likely to see some profit taking.....buy on the dips.....GLTA